Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
Randomized controlled open trial
Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Randomized controlled open trial
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
Convalescent plasma
Randomized controlled open trial
Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Randomized controlled open trial
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Colchicine
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Dexamethasone
Randomized controlled open trial
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
Budesonide
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/31/2021
Tocilizumab
Randomized controlled open trial
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Rosuvastatin
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/20/2021
Emtricitabine
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Tenofovir
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Corticosteroids
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Ritonavir
Randomized controlled open trial
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Siltuximab
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/29/2021
Favipiravir
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
IVIg
Randomized controlled open trial
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Interferon alfa
Randomized controlled open trial
Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021
Chloroquine phosphate
Randomized controlled open trial
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021